The medications aren’t just for diabetes and obesity, but they also aren’t for every ailment.

Chronic kidney disease now ranks as the ninth leading cause of death globally, affecting 788 million people worldwide, according to major health study.

The number of adults living with chronic kidney disease (CKD) has more than doubled since 1990, reaching nearly 800 million ...

The White House is expected to announce a deal for lower prices of obesity drugs from Novo Nordisk and Eli Lilly on Thursday ...

President Donald Trump’s deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

A new directive by President Donald Trump’s administration could make it more difficult for foreigners to visit or live in ...

Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma company’s aging blockbusters. Late Friday, after a dramatic bidding war, he ...

A sweeping global study reveals that chronic kidney disease now affects nearly 800 million people and has become one of the world’s top 10 causes of death. A new global analysis reveals that more ...

Foreign nationals seeking to stay in the US could be denied visas if they have diabetes, heart disease and obesity, among ...

Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose ...

As Pfizer acquires MET-097 maker Metsera, phase 2 data show potential for greater tolerability and once-monthly dosing.

WASHINGTON -- Daily treatment with the novel drug saroglitazar significantly reduced liver fat in women with metabolic ...